Chambal Fertilisers and Chemicals (CHAMBLFERT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 Mar, 2026Business highlights
Over 40 years in the industry with 3.4 MMTPA urea capacity and ~10% market share, operating three plants at a single location and serving 14 states through 76,000+ retailers and 4,700+ dealers.
Asset-light model for complex fertilisers, crop protection chemicals, and specialty nutrients, with a strong presence in non-subsidized segments under the "Uttam" brand.
Diversification into industrial chemicals with a 2.4 lakh MTPA Technical Ammonium Nitrate (TAN) plant nearing completion.
Strategic joint venture in Morocco (IMACID) for phosphoric acid, contributing stable earnings.
Recognized for operational excellence, energy efficiency, and sustainability with multiple national awards.
Financial performance
Operational income for FY25 was INR 166,462 Mn, with EBITDA of INR 24,842 Mn and PAT of INR 16,568 Mn; EBITDA margin improved to 14.92%.
Net debt to equity is nil as of FY25, reflecting a strong balance sheet and disciplined capital allocation.
ROE and ROCE for FY25 stood at 21% and 25% respectively, indicating robust returns.
Completed a INR 700 crore share buyback, further strengthening capital structure.
Working capital days reduced to 57 in FY25, with a significant drop in finance costs.
Segment overview
Urea accounts for 56% of revenue, complex fertilisers 37%, and crop protection chemicals, specialty nutrients & seeds 7% for 9M-FY26.
Urea production and sales volumes remained stable, with energy-efficient operations and government-backed cost-plus pricing.
Complex fertilisers benefit from the Nutrient Based Subsidy scheme, with ~5-6% market share in DAP, NPK, and MOP.
Crop protection and specialty nutrients segment has a 3% market share, growing at a 19% CAGR, and operates on a higher-margin, asset-light model.
Latest events from Chambal Fertilisers and Chemicals
- Q1 FY27 delivered higher margins and profit despite lower revenue, with robust segment performance.CHAMBLFERT
Q1 26/2731 Jul 2026 - EBITDA and PAT rose in FY25, led by CPC & SN growth; Rs. 5.00/share dividend recommended.CHAMBLFERT
Q4 24/259 Jul 2026 - Q3 saw strong profit and revenue growth, new product launches, and major capacity expansions.CHAMBLFERT
Q3 24/258 Jul 2026 - FY26 saw 25% revenue growth, 18% profit rise, and major TAN plant commissioning.CHAMBLFERT
Q4 25/268 Jul 2026 - EBITDA and PAT rose sharply, with zero long-term debt and strong crop protection growth.CHAMBLFERT
Q1 24/258 Jul 2026 - EBITDA and PAT surged year-over-year, supported by urea and CPCSM growth, and interim dividend declared.CHAMBLFERT
Q2 24/258 Jul 2026 - Strong revenue and profit growth, new launches, and interim dividend highlight robust performance.CHAMBLFERT
Q2 25/261 Jul 2026 - Strong Q3/9M growth driven by complex fertilizers, specialty nutrients, and TAN project progress.CHAMBLFERT
Q3 25/2612 Apr 2026 - Profits and revenue rose on CPC, SN, and biologicals growth; TAN project 80% complete.CHAMBLFERT
Q1 25/2614 Oct 2025